Martin L. Yarmush, M.D., Ph.D.
Chief Scientific Adviser
martinyarmush
Professor Yarmush is an internationally recognized bioengineer and translational scientist whose laboratory has been a leader in the fields of cell & tissue engineering and microfabrication. Dr. Yarmush currently serves as the: Paul and Mary Monroe Chair and Distinguished Professor of Biomedical and Chemical Engineering in the School of Engineering at Rutgers University; Director of the Center for Innovative Ventures of Emerging Technologies (CIVET) at Rutgers; and Director of the Center for Engineering in Medicine at the Massachusetts General Hospital/Harvard Medical School. Over the last 30+ years, Dr. Yarmush has published more than 500 refereed journal articles, has mentored over 160 postdoctoral fellows and graduate students, and has co-authored more than 50 patents and patent applications. A frequent invited speaker at major conferences and symposia, and winner of over 30 local and national awards (including membership in the US National Academy of Engineering and the National Academy of Inventors), Dr. Yarmush is known worldwide as one of the leading investigators in the area of molecular and cellular bioengineering. He has made seminal contributions to the fields of tissue engineering and regenerative medicine, BioMEMS and nanotechnology, applied immunology and biotechnology, metabolic engineering, and genomics and proteomics technologies. Advances with which he has been credited include innovative cell culture systems and tissue constructs, microfabricated bioartificial organ systems, organ revitalization techniques, targeted therapies for tumors and infections, recombinant protein and recombinant retrovirus production and purification techniques, and microfabricated living cell arrays. Dr. Yarmush received his MD degree from Yale University and completed PhD work at The Rockefeller University (biophysical chemistry and immunology) and MIT (chemical engineering).
BioMEMS, applied immunology, metabolic engineering, and genomics and proteomics technologies. Advances with which he has been credited include innovative cell culture systems, microfabricated bioartificial organs development, targeted therapies for tumors and infections, recombinant protein and recombinant retrovirus production and purification techniques, and microfabricated living cell arrays. Dr. Yarmush received his MD degree from Yale University and completed PhD work at The Rockefeller University (physical biochemistry) and MIT (chemical engineering).